$MCS

GERSHOWITZ DIANE M sold $1.4M of MCS (indirect holdings)

GERSHOWITZ DIANE M sold 50,000 indirectly-held shares of MARCUS CORP (MCS) at $27.61 ($1.38M total) on 2026-09-23.

Original reporting
SEC EDGAR · GERSHOWITZ DIANE M
Published Sep 24, 2026, 9:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MCS
Neutral
medium confidence
Mentioned
$MCS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MCSNeutralLow
01

Why it matters

The insider sale is modest and unlikely to move the stock significantly; investors may monitor for further sales.

02

Market read

Routine insider sale with limited market impact.

03

Timing

filed today

Relevance 6/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$MCSNeutralMedium confidence
Context

Director Diane Gershowitz sold 50,000 shares for $1.38M, reducing her stake to 125,617 shares.

Expected impact

Potential short-term pressure of 0.5‑1% if market reacts to insider sell.

Evidence & confidence

Sale amount is under $2M and represents a small percentage of total holdings; typical market reaction is limited.

Key entities

  • Marcus Corp

    Issuer of the Form 4 filing.

  • Diane Gershowitz

    Director and 10% owner of Marcus Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMCMed

AMC vs. MCS: Which Theater Stock Is the Better Buy Today?

AMC and Marcus (MCS) report Q2 2026 earnings growth, with AMC showing 14.2% revenue increase and MCS up 16.6% in theater admissions. AMC's adjusted EBITDA rose 70% to $321.4M, while MCS's theater-adjusted EBITDA increased 37% to $36.3M. MCS has lower leverage (1.1x) and stronger free cash flow, while AMC's recovery hinges on box office growth. Analysts favor MCS for its diversified earnings and higher estimate revisions.

$MCSMed

Marcus Corp Q2 Profit Rises; Shares Climb

Marcus Corp. (MCS) reported Q2 results with net earnings up 116.4% to $15.84M, or $0.51/share, and operating income rising to $27.07M from $13.01M. Adjusted EBITDA increased 43% to $46.2M. Total revenue grew 12.5% to $231.74M. Shares were up about 8.7% at $27.14, per NYSE.

$MCSMed

MARCUS CORP (MCS): Results of Operations and Financial Condition

MARCUS CORP (MCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MARCUS CORPORATION REPORTS SECOND QUARTER FISCAL 2026 RESULTS Marcus Corporation reports strong net earnings and highest revenue and Adjusted EBITDA in a second quarter since the pandemic; Marcus Theatres and Marcus Hotels & Resorts outperformed their respective indu

$IMAXMed

Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks By Investing.com

Christopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.